Likewise, as shown in Fig. 6B, in children with unconfirmed TB at the end of ATT, the plasma levels of CCL1 (GM of 42.5 pg/ml in pre-T vs. 27.7 pg/ml in post-T), CCL11 (GM of 13 pg/ml in pre-T vs. 14.1 pg/ml in post-T), CXCL1 (GM of 77.7 pg/ml in pre-T vs. 30.4 pg/ml in post-T) and CXCL10 (GM of 105 pg/ml in pre-T vs. 21.9 pg/ml in post-T) were also significantly diminished in comparison to pre-treatment levels. The gene discussed is CXCL10; the disease is tuberculosis.